Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Pulsenmore PLSM Climbs 843 Resistance at 500 in Focus 20260515 elf Beauty ELF Q1 2026 Earnings 124 EPS Surges Past 073 Estimates Could Amazon Reach New Heights in 2026 What Market Trends Suggest Alphabets Google IO 2026 AI Showdown That Could Define the Next Chapter for the Tech Giant ASEAN Manufacturers Reduce Workforce Amid Worsening Iran War Fallout RBIs Rate Cut May Signal Shift in Monetary Policy Framework Nomura Suggests DeepSeek AI Model Triggers SafeHaven Flows Yen and Swiss Franc Strengthen Against Dollar ONGC Taps BP as Technology Partner for Western Offshore Fields Expanding Collaboration Wall Streets Complacency May Amplify Future Market Risks Goldman Sachs Tapped to Lead SpaceX IPO in Potential Historic Market Debut JBL Q1 2026 Earnings EPS Surges Past Estimates with 62 Beat ATPC Q4 2024 Earnings Net Loss of 020 Per Share Stock Rises Sharply PROP Q1 2026 Earnings Significant EPS Miss but Stock Climbs 9 Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances BANX Q4 2022 Earnings EPS Slightly Misses Estimates Amid Challenging Market Conditions Similarweb Q1 2026 Earnings EPS Misses Estimates but Stock Jumps 9 on Operational Progress Harvard Bioscience Slips as Traders Assess Support Levels HBIO Down Nearly 3 Tivic Health Systems TIVC Holds Steady at 140 as Key Support and Resistance Levels Define Range Gesher Acquisition Corp II Warrants GSHRW Hold Steady at 022 Amid Quiet Trading Evolution Petroleum EPM Gains 123 as Shares Test Key Resistance Level Wynn Resorts WYNN Surges 34 as Bulls Test Key Resistance at 10628 Mondelez International MDLZ Edges Lower Amid Steady Market Conditions Apple Hospitality REIT Holds Steady Near 1480 as Support Levels Tighten Hanmi Financial HAFC Edges Lower Amid Broader Banking Sector Weakness Artius II Acquisition Inc AACB Holds Steady Near NAV as Market Awaits Business Combination Neumora Therapeutics NMRA Holds Steady at 185 as Consolidation Continues